Armand Earl Ko Dichosa

Title: Armand Earl Ko Dichosa: Innovator in Monoclonal Antibodies

Introduction

Armand Earl Ko Dichosa is a notable inventor based in Los Alamos, NM (US). He has made significant contributions to the field of biotechnology, particularly in the development of synthetic anti-plague antibodies. His work focuses on creating monoclonal antibodies that can specifically bind to the F1 antigen with high affinity.

Latest Patents

Dichosa holds a patent for synthetic anti-plague antibodies. This patent describes monoclonal antibodies that specifically bind the F1 antigen, which is crucial for the detection and diagnosis of plague infections. Additionally, the patent outlines the use of immunoconjugates of these monoclonal antibodies combined with a radionuclide for the treatment of infections.

Career Highlights

Armand Earl Ko Dichosa is currently employed at Triad National Security, LLC. His role at the company allows him to engage in cutting-edge research and development in the field of immunology and infectious diseases.

Collaborations

Dichosa has collaborated with notable colleagues, including Laura Margaret Lilley and Nileena Velappan. These collaborations have contributed to the advancement of his research and the successful development of innovative solutions in healthcare.

Conclusion

Armand Earl Ko Dichosa is a pioneering inventor whose work in monoclonal antibodies has the potential to significantly impact the diagnosis and treatment of plague infections. His contributions to biotechnology exemplify the importance of innovation in addressing public health challenges.